Proteinase Inhbitors & Crystallin Fragments in Cataract
Proteinase Inhbitors & Crystallin Fragments in Cataract
批准号:
7399654
负责人:
Om Prakash Srivastava
金额:
$5.35万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-07-01 至 2009-03-31
关键词:
Active SitesAgeAgingAmino AcidsBinding SitesCataractComplexCrystallinsDetergentsDevelopmentDimerizationEndopeptidasesEnzyme ActivationEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesExhibitsFilamentGoalsHumanHuman DevelopmentHydrolysisHydrophobicityIn VitroInvestigationKineticsLaboratoriesLens OpacitiesLiteratureMapsMembraneModificationMolecularN-terminalObject AttachmentPeptide HydrolasesPlayPost-Translational Protein ProcessingProcessProgress ReportsPropertyProteinsProteolysisRecombinantsRegulationRelative (related person)Research PersonnelResearch Project GrantsRoleSenile CataractSodium DeoxycholateStructureSurfaceTestingWaterage relatedaspergillopepsin IIbasecovalent bondcrosslinkenzyme activityfilensinin vivoinhibitor/antagonistlenslens proteinmethionyltryptophanmutantphakininprogramsproteinase In
中文摘要
点击翻译按钮获取中文摘要
英文摘要
During aging, an increasing proportion of total lens proteins becomes water insoluble (Wl), either due to aggregation
and/or cross-linking. A further cross-linking of these species into covalent multimers is believed to cause opacity
during age-related(senile) cataract development.A variety of post-translational modifications of crystallins are
described in the literature as causativefactors for cross-linking mechanism, but their relative roles remain unclear.
Because the senile cataract development is a slow process and sometimes takes years, few specific modifications
might act as triggersto acceleratethe cross-linking mechanism and cause lens opacity. Our results show that
modified crystallinfragments play an active role in the crystallin cross-linking process. To understand such a role of
crystallin fragments,one must determine their origin, post-translational modifications and cross-linking mechanism
in order to implicatethem as a causativefactor. Based on our results, we have hypothesized that bA3/A1 -crystallin
contains proteinaseactivity, but the activity is regulated in vivo because the enzyme activity needed activation, and
the active enzyme is inhibited by a-crystallin. The bA3/A1-crystallin proteinase proteolyses a-, b- and g-crystallins,
and the crystallin fragments undergo post-translationalmodifications, leading to their cross-linking per se and with
phakinin and filensin (lens beaded filament proteins) to form covalent multimers. These covalent multimers cause
lens opacity. To test the above hypothesis,the proposed studies will be focused to answer the following three major
questions: (A) What is the molecular mechanism of activation of an Arg-bond hydrolyzing proteinase activity of bA3/
A1-crystallin? (B) How is the b A3/A1-crystaltin proteinase activity regulated in vivo? (C) What is the covalent cross-
linking mechanismof post-translationallymodified crystallin fragments per se and with phakinin and filensin?
The above studieswill provide an answerto the central question of how opacity develops during age-related
cataract development. Because human lenses will be used in these studies, the findings will be relevant in
elucidating the role of b A3/A1-crystal!in proteinase in the proteolysis of crystallins, their regulation in vivo, and in
particular the mechanismof cross-linkingof crystallinfragments per se and with phakinin and filensin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanism of αAN101D-Transgene-Induced Age-Related Cataract
-
批准号:10597653
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2020
-
负责人:Om Prakash Srivastava
-
依托单位:
Molecular Mechanism of αAN101D-Transgene-Induced Age-Related Cataract
-
批准号:10376357
-
项目类别:
-
资助金额:$38.29万
-
财政年份:2020
-
负责人:Om Prakash Srivastava
-
依托单位:
CORE--COMPUTER
-
批准号:6325810
-
项目类别:
-
资助金额:$10.18万
-
财政年份:2000
-
负责人:Om Prakash Srivastava
-
依托单位:
CORE--COMPUTER
-
批准号:6192093
-
项目类别:
-
资助金额:$10.18万
-
财政年份:1999
-
负责人:Om Prakash Srivastava
-
依托单位:
SMALL INSTRUMENTATION GRANT
-
批准号:2165066
-
项目类别:
-
资助金额:$0.9万
-
财政年份:1994
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:6131752
-
项目类别:
-
资助金额:$24.03万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:6518358
-
项目类别:
-
资助金额:$25.58万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhbitors & Crystallin Fragments in Cataract
-
批准号:7115412
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhibitors and Crystallin Fragments in Cataract
-
批准号:8370202
-
项目类别:
-
资助金额:$36.63万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Project title Proteinase Inhibitors & Crystallin Fragments in Cataract
-
批准号:7654940
-
项目类别:
-
资助金额:$36.58万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE, INHIBITOR & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:2160129
-
项目类别:
-
资助金额:$12.91万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhbitors & Crystallin Fragments in Cataract
-
批准号:6921646
-
项目类别:
-
资助金额:$32.21万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:6890150
-
项目类别:
-
资助金额:$1.45万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhbitors & Crystallin Fragments in Cataract
-
批准号:7032943
-
项目类别:
-
资助金额:$31.97万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhibitors and Crystallin Fragments in Cataract
-
批准号:8514613
-
项目类别:
-
资助金额:$34.79万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhibitors and Crystallin Fragments in Cataract
-
批准号:8857466
-
项目类别:
-
资助金额:$35.89万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:2444292
-
项目类别:
-
资助金额:$12.54万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:2710917
-
项目类别:
-
资助金额:$13.04万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:2160133
-
项目类别:
-
资助金额:$14.71万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:6384525
-
项目类别:
-
资助金额:$21.53万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: